Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY.
The item "Cash-Flow-Per-Share" stands at 719.75 Japanese Yens as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash Flow Per Share" stands at 719.75 JPY. This represents an increase of 11.25 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 41.90 percent compared to the value the year prior.
The 1 year change in percent is 41.90.
The 3 year change in percent is 22.64.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Flow Per Share | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Flow Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flow Per Share | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Flow Per Share | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Flow Per Share | 280,205,508,085.11 |